BIOSYNEX
LIVE

Serial Number

79313560

Owner

BIOSYNEX

Attorney

Joseph Sofer

Filing Date

May 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BIOSYNEX Trademark

Serial Number: 79313560 • Registration: 7159430

BIOSYNEX is a trademark filed by BIOSYNEX on May 11, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BIOSYNEX (8 trademarks)

12, rue Ettore Bugatti

Entity Type: 98

Trademark Details

Filing Date

May 11, 2021

Registration Date

September 12, 2023

Published for Opposition

June 27, 2023

Goods & Services

Chemical and biological reagents and products for medical or veterinary purposes, namely, reagents for use in diagnostic tests, reagents for use in diagnostic tests for screening purposes, reagents for medical use, chemical reagents for medical purposes, diagnostic biomarker reagents for medical use; immunoassay reagents for medical use, reagent paper for medical purposes; reagents and preparations for pregnancy tests, chemical preparations for use in DNA medical analysis and Chemicals for use in RNA analysis for medical purposes; diagnostic products for medical purposes, namely, medical diagnostic test strips for the detection of coronavirus, viruses, bacteria or parasite for medical purposes, medical diagnostic test strips for measuring blood glucose levels, medical diagnostic test strips for measuring cholesterol levels, triglycerides, cardiac markers or any other biomedical marker; testing kits comprised of medical diagnostic agents, preparations and substances for medical purposes for use in disease detection, namely, coronavirus, HIV, respiratory viral infections, hepatitis B, hepatitis C, influenza, infectious mononucleosis, dengue, norovirus, rotavirus, adenovirus, urinary tract infections, colorectal cancer, C-reactive protein, cyclic citrullinated peptide, premature rupture of the fetal membranes, Chlamydia trachomatis, helicobacter pylori, legionnaire's disease, pneumonia, syphilis, tetanus, malaria, mycoses, herpes, rubella, whooping cough, Lyme disease; preparations and substances for medical purposes for use in drugs detection, namely, amphetamines, buprenorphine, cocaine, cotinine, methadone, fentanyl, methamphetamines, morphine, oxycodone, phencyclidine, cannabis, tramadol; pregnancy test kits and ovulation test kits for home use; diagnostic test kits comprised of medical diagnostic, for medical purposes for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; in vitro diagnostic preparations for medical use for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; self-testing diagnostic kits comprising in vitro diagnostic agents, preparations and substances for medical purposes for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic test kits for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic reagents and assays for testing of body fluids for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic reagents; chemical reagents for medical or veterinary purposes

Chemical products for use in industry and science; chemical reagents, other than for medical or veterinary purposes ; diagnostic preparations other than for medical or veterinary purposes ; Chemically-treated nonmedical strips for chemical and biological analysis

Diagnostic apparatus for medical purposes, namely, blood testing apparatus; genetic testing apparatus for medical purposes; diagnostic test readers for medical use; medical diagnostic apparatus for testing DNA and RNA samples; medical apparatus and instruments, namely, instruments for loop-mediated isothermal amplification for medical purposes; quantitative Polymerase Chain Reaction [PCR] instruments for medical use; real-time polymerase chain reaction (PCR) instruments for medical purposes; testing instruments for medical diagnostic purposes, namely, for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; capillary tubes for samples; medical specimen cups; specimen cup holders; apparatus for taking body fluid samples, namely, medical devices for obtaining body fluid samples; gloves for medical purposes, sanitary masks for medical purposes, thermometers for medical use, chemically activated hot and cold gel packs for medical purposes; cooling patches for medical purposes; Ice bags for medical purposes, first-aid cooling patches, elastic bandages, Bandages for orthopaedic purposes

Chemical analysis and research services; biological research; bacteriological research; chemical research; pharmaceutical research services; calibration of devices employed in such services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 2, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 12, 2023 FICS
FINAL DISPOSITION PROCESSED
Dec 12, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 12, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 12, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 12, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 27, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Jun 26, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 7, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 7, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 24, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 24, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 24, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 24, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 24, 2023 CNEA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 28, 2023 JURT
EX PARTE APPEAL-INSTITUTED
Mar 9, 2023 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Mar 9, 2023 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 6, 2023 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 23, 2022 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 9, 2022 GNFN
FINAL REFUSAL E-MAILED
Sep 9, 2022 GNFR
FINAL REFUSAL WRITTEN
Sep 9, 2022 CNFR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 23, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 23, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 23, 2022 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2022 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 7, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 7, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 20, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 19, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 29, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 23, 2021 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 17, 2021 SDRC